Cardiovascular Disease

Food, housing and financial insecurity each greatly increased the odds of CVD, according to data presented at the virtual American College of Cardiology Scientific Session.

“Multiple gaps exist in the routine cardiovascular care of the cancer survivor, especially around primary prevention efforts and surveillance for incident cardiovascular disease [CVD],” Steven Philips, MD, PhD, cardiology fellow at UT Southwestern Medical Center, and Vlad G. Zaha, MD, PhD, assistant professor in the center’s division of cardiology, wrote in a column for Cardiology Today.

Psychiatric patients have a higher prevalence of metabolic syndrome than the general population and may not receive adequate treatment for metabolic disruptions, according to results of a Swiss population-based cohort study published in Journal of Clinical Psychiatry.

Exposure to ambient particulate matter less than 2.5 µm may affect CV benefits from intensive BP lowering, according to a post hoc analysis of the SPRINT trial presented at the American College of Cardiology Scientific Session.

A larger thigh circumference may be associated with lower blood pressure and a reduced risk for developing cardiovascular disease among people with overweight or obesity, according to findings published in Endocrine Connections.

In the United States, age-adjusted deaths from hypertension-related CVD increased from 2007 to 2017, with the trend accelerating starting in 2012 and the highest rate in the rural South region, according to findings presented at the virtual American College of Cardiology Scientific Session.

SCOTTSDALE, Arizona — There is an important unmet need for multidisciplinary care models to utilize the novel antihyperglycemic agents to lower cardiorenal outcomes in patients, according to an expert at the Cardio Renal Metabolic Conference.

The extent and magnitude of metabolic adaptation to chronic exercise training in men were greater than originally believed, likely due to increased consumption of ketone body substrates and fatty acid, researchers reported in Cardiovascular Research.

Christopher B. Newgard, PhD, is an endocrinology veteran and a metabolic expert. For his efforts in investigating mechanisms of metabolic regulation and fueling homeostasis in mammalian systems, the Endocrine Society conferred on him its 2020 Outstanding Innovation Award.

A pooled analysis of three phase 3 trials assessing inclisiran found that the agent safely lowered LDL in patients with several conditions including atherosclerotic CVD, heterozygous familial hypercholesterolemia and ASCVD risk equivalents, according to data presented at the American College of Cardiology Scientific Session.